These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29250325)

  • 1. Modern biotechnology-based therapeutic approaches against HIV infection.
    Imran M; Waheed Y; Ghazal A; Ullah S; Safi SZ; Jamal M; Ali M; Atif M; Imran M; Ullah F
    Biomed Rep; 2017 Dec; 7(6):504-507. PubMed ID: 29250325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.
    Méndez C; Ahlenstiel CL; Kelleher AD
    World J Virol; 2015 Aug; 4(3):219-44. PubMed ID: 26279984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.
    Huang Z; Tomitaka A; Raymond A; Nair M
    Gene Ther; 2017 Jul; 24(7):377-384. PubMed ID: 28471431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
    Xiao Q; Guo D; Chen S
    Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas.
    Herrera-Carrillo E; Berkhout B
    Biochem Soc Trans; 2016 Oct; 44(5):1355-1365. PubMed ID: 27911718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.
    Almeida MJ; Matos A
    Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of HIV Infection: Current Approaches and Prospects.
    Prokofjeva MM; Kochetkov SN; Prassolov VS
    Acta Naturae; 2016; 8(4):23-32. PubMed ID: 28050264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic application of CRISPR/Cas9 technologies for HIV.
    Saayman S; Ali SA; Morris KV; Weinberg MS
    Expert Opin Biol Ther; 2015 Jun; 15(6):819-30. PubMed ID: 25865334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for HIV-1 suppression through key genes and cell therapy.
    Sorokina A; Anchakova E; Dashinimaev E
    Front Med (Lausanne); 2023; 10():1259995. PubMed ID: 38093984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
    Zhu W; Lei R; Le Duff Y; Li J; Guo F; Wainberg MA; Liang C
    Retrovirology; 2015 Feb; 12():22. PubMed ID: 25808449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The latest evidence for possible HIV-1 curative strategies.
    Pham HT; Mesplède T
    Drugs Context; 2018; 7():212522. PubMed ID: 29497452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fight fire with fire: Gene therapy strategies to cure HIV.
    Huyghe J; Magdalena S; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):747-758. PubMed ID: 28692305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection.
    Allen AG; Chung CH; Atkins A; Dampier W; Khalili K; Nonnemacher MR; Wigdahl B
    Front Microbiol; 2018; 9():2940. PubMed ID: 30619107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards therapeutic application of RNA interference for HIV infection.
    Singh SK; Gaur RK
    BioDrugs; 2009; 23(5):269-76. PubMed ID: 19754217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Garbelli A; Riva V; Crespan E; Maga G
    Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.